Nucleic acid synthesis in bacteria

Nucleic acid synthesis in bacteria" describes the overall set of enzymatic processes enabling bacteria to create DNA and RNA from nucleotide precursors. These pathways are fundamental to bacterial replication, survival, and the expression of genetic information[2][6]. Because bacteria rely on unique enzyme machinery such as DNA gyrase, topoisomerase IV, and bacterial RNA polymerase, these processes are prime targets for antibiotic intervention. Drugs like quinolones and rifamycins exploit differences between bacterial and human nucleic acid enzymes to selectively inhibit bacterial growth or kill bacteria[7]. However, since this is not a single molecular target but rather a multistep process governed by several enzymes and proteins (DNA polymerases, topoisomerases, RNA polymerase, primase, etc.), "nucleic acid synthesis in bacteria" should not be considered a canonical, druggable entity. This entry represents a biological pathway rather than a distinct, structurally defined biomolecule or receptor, and thus is incorrect for structured target annotation purposes. Where possible, downstream efforts should focus on individual enzymatic components, such as "DNA gyrase (GyrA/GyrB)", "Topoisomerase IV (ParC/ParE)", or "DNA-dependent RNA polymerase (RpoB etc.)".

Inhibition of DNA gyrase and topoisomerase IV (blocks DNA supercoiling and replication); Inhibition of DNA-dependent RNA polymerase (blocks RNA synthesis initiation)